Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1962 Mar;41(3):543–553. doi: 10.1172/JCI104508

MECHANISM OF ACTION OF THROMBIN ON PLATELETS*

Hans J Schmid 1, Dudley P Jackson 1, C Lockard Conley 1
PMCID: PMC290948  PMID: 14498649

Full text

PDF
543

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALEXANDER B., GOLDSTEIN R., RICH L., LE BOLLOC'H A. G., DIAMOND L. K., BORGES W. Congenital afibrinogenemia; a study of some basic aspects of coagulation. Blood. 1954 Sep;9(9):843–865. [PubMed] [Google Scholar]
  2. BERGSAGEL D. E. Viscous metamorphosis of platelets; morphological platelet changes induced by an intermediate product of blood thromboplastin formation. Br J Haematol. 1956 Apr;2(2):130–138. doi: 10.1111/j.1365-2141.1956.tb06821.x. [DOI] [PubMed] [Google Scholar]
  3. BOUNAMEAUX Y. Sur le mécanisme de la rétraction du caillot et de la métamorphose visqueuse des plaquettes. Rev Hematol. 1957 Jan-Mar;12(1):16–34. [PubMed] [Google Scholar]
  4. BRECHER G., CRONKITE E. P. Morphology and enumeration of human blood platelets. J Appl Physiol. 1950 Dec;3(6):365–377. doi: 10.1152/jappl.1950.3.6.365. [DOI] [PubMed] [Google Scholar]
  5. BRINKHOUS K. M., LEROY E. C., CORNELL W. P., BROWN R. C., HAZLEHURST J. L., VENNART G. P. Macroscopic studies of platelet agglutination; nature of thrombocyte agglutinating activity of plasma. Proc Soc Exp Biol Med. 1958 Jun;98(2):379–383. doi: 10.3181/00379727-98-24050. [DOI] [PubMed] [Google Scholar]
  6. CORN M., JACKSON D. P., CONLEY C. L. Components of blood necessary for clot retraction. Bull Johns Hopkins Hosp. 1960 Aug;107:90–104. [PubMed] [Google Scholar]
  7. HARTMANN R. C., CONLEY C. L. Clot retraction as a measure of platelet function. I. Effects of certain experimental conditions on platelets in vitro. Bull Johns Hopkins Hosp. 1953 Dec;93(6):355–369. [PubMed] [Google Scholar]
  8. HAYDON G. B. Electron microscopic observations of blood platelets and fibrin formation. AMA Arch Pathol. 1957 Oct;64(4):393–397. [PubMed] [Google Scholar]
  9. HJORT P. Platelet accelator: identical to proaccelerin and adsorbed from plasma? Scand J Clin Lab Invest. 1955;7(1):97–98. doi: 10.3109/00365515509134105. [DOI] [PubMed] [Google Scholar]
  10. JOHNSON S. A., SCHNEIDER C. L. The existence of antifibrinolysin activity in platelets. Science. 1953 Feb 27;117(3035):229–230. [PubMed] [Google Scholar]
  11. LUESCHER E. F. [Thrombocyte factors]. Ergeb Physiol. 1959;50:1–74. [PubMed] [Google Scholar]
  12. QUICK A. J., HUSSEY C. V. The mechanism of clot retraction. Science. 1950 Nov 10;112(2915):558–559. doi: 10.1126/science.112.2915.558. [DOI] [PubMed] [Google Scholar]
  13. SALMON J., BOUNAMEAUX Y. Situation du fibrinogene décelé dans les thrombocytes bovins isolés et lavés. Arch Int Physiol Biochim. 1957 Sep;65(3):502–503. [PubMed] [Google Scholar]
  14. SALMON J., VERSTRAETE M., BOUNAMEAUX Y. Fibrinogène plaquettaire et afibrinogénémie. Arch Int Physiol Biochim. 1957 Dec;65(4):632–634. [PubMed] [Google Scholar]
  15. SCHMID H. J. Die Bedeutung des Serum Prothrombingehaltes in der Testung auf antithrombozytäre Antikörper. Vox Sang. 1958 May;3(3):162–178. doi: 10.1111/j.1423-0410.1958.tb03609.x. [DOI] [PubMed] [Google Scholar]
  16. SELIGMANN M., GOUDEMAND B., JANIN A., BERNARD J., GRABAR P. Etude immunochimiques sur la présence de fibrinogène dans des extraits de plaquettes humaines lavées et dans certains extraits leucocytaires. Rev Hematol. 1957 Jul-Aug;12(3):302–327. [PubMed] [Google Scholar]
  17. SENTA S. S., ROSENTHAL R. L. Intermediate stages in platelet alterations during coagulation. Acta Haematol. 1958 Apr-May;19(4-5):209–221. doi: 10.1159/000205436. [DOI] [PubMed] [Google Scholar]
  18. STEFANINI M., SILVERBERG J. H. Studies on platelets. I. The relationship of platelet agglutination to the mechanism of blood coagulation. Am J Clin Pathol. 1951 Nov;21(11):1030–1038. doi: 10.1093/ajcp/21.11.1030. [DOI] [PubMed] [Google Scholar]
  19. VANDENBROUCKE J., VERSTRAETE M., VERWILGHEN R. L'afibrinogénémie congénitale; présentation d'un nouveau cas et revue de la littérature. Acta Haematol. 1954 Aug;12(2):87–105. doi: 10.1159/000204605. [DOI] [PubMed] [Google Scholar]
  20. ZUCKER M. B., BORRELLI J. Relationship of some blood clotting factors to serotonin release from washed platelets. J Appl Physiol. 1955 Jan;7(4):432–442. doi: 10.1152/jappl.1955.7.4.432. [DOI] [PubMed] [Google Scholar]
  21. ZUCKER M. B., BORRELLI J. Some effects of divalent cations on the clotting mechanism and the platelets of EDTA blood. J Appl Physiol. 1958 May;12(3):453–460. doi: 10.1152/jappl.1958.12.3.453. [DOI] [PubMed] [Google Scholar]
  22. ZUCKER M. B., BORRELLI J. Viscous metamorphosis produced by chilling and by clotting failure to find specific defect of viscous metamorphosis in PTA syndrome. Thromb Diath Haemorrh. 1960 Jun 15;4:424–434. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES